SCHEMBL4924503

SCHEMBL4924503

CC(C)Oc1ccc(-n2c(C(=O)O)c(N(C)C(=O)C(C)(C)C)c3cc(Oc4ccc(OC(F)(F)F)c(F)c4)ccc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PTGES O14684 3/20 0.39
PPARG P37231 16/20 0.39
PPARA Q07869 7/20 0.39
SCN9A Q15858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4926810 0.90 PPARG (0.42) PTGESPPARGPPARA
SCHEMBL4914604 0.86 PPARG (0.48) PTGESPPARGPPARA
SCHEMBL4914032 0.85 PPARG (0.42) PTGESPPARGPPARA
SCHEMBL4924007 0.83 PPARG (0.47) PTGESPPARGPPARA
SCHEMBL4922575 0.82 PPARG (0.41) PTGESPPARGPPARA
SCHEMBL4924514 0.82 PTGES (0.41) PTGESPPARGPPARA
SCHEMBL4922054 0.78 PPARG (0.47) PTGESPPARGPPARA
SCHEMBL4918420 0.77 PPARG (0.43) PTGESPPARGPPARA
SCHEMBL4923431 0.76 PTGES (0.40) PTGESPPARGPPARA
SCHEMBL3002052 0.75 PPARG (0.45) PTGESPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249091-A1 Indoles Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249091-A1 Indoles Useful in the Treatment of Inflammation IDO1, IDO2, ARG1 PTGES 35/4885PPARG 2586/4885PPARA 3339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.